NCT05571059Phase 2Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Study sponsor: Cumberland Pharmaceuticals

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-01Estimated
Enrollment · participants128Estimated
Source updated2026-09-02Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Jan 2027. After: Jan 2028.

Check registry source

· 1 field changed

Primary completion date changed

Before: Jan 2026. After: Jan 2027.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview